A Neonatal Thrombosis Patient Treated Successfully with Recombinant Tissue Plasminogen Activator
نویسندگان
چکیده
منابع مشابه
A Neonatal Thrombosis Patient Treated Successfully with Recombinant Tissue Plasminogen Activator
UNLABELLED Herein we report an asphyctic preterm neonate with respiratory distress and prothrombotic risk factors that responded positively to rtPA treatment following 2 attacks of acute thrombosis. CONFLICT OF INTEREST None declared.
متن کاملA neonatal thrombosis patient treated successfully with recombinant tissue plasminogen activator Rekombinan doku plazminojen aktivatörü ile başarılı bir şekilde tedavi edilmiş bir neonatal tromboz olgusu
Kemal Erdinç1, Serdar Ümit Sarıcı2, Orçun Dabak1, Orhan Gürsel3, Adem Güler4, Ahmet Emin Kürekçi3, Fuat Emre Canpolat2 1Department of Pediatrics, Gülhane Military Medical Academy, Ankara, Turkey 2Department of Pediatrics, Division of Neonatology, Gülhane Military Medical Academy, Ankara, Turkey 3Department of Pediatrics, Division of Hematology, Gülhane Military Medical Academy, Ankara, Turkey 4...
متن کاملOptimizing refolding condition for recombinant tissue plasminogen activator
Low molecular size additives such as L-arginine and the redox compounds have been used both in the culturemedium and in vitro refolding to increase recombinant proteins production. Additives increase proteinrefolding and yield of active proteins by suppressing aggregate formation or enhancing refolding process.In this work, a comparative study was performed on refolding of rec...
متن کاملThe Outcome of Treatment With Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke
Background: Thrombolytic therapy is the recommended treatment of acute ischemic stroke. It is crucial to evaluate the treatment results with recombinant Tissue Plasminogen Activator (r-TPA) in patients with acute stroke. Objectives: This study aimed to evaluate treatment outcomes with r-TPA in patients with acute stroke in a referral stroke center in Iran. Materials & Methods: In this retrosp...
متن کاملMassive pulmonary embolism during pregnancy successfully treated with recombinant tissue plasminogen activator: a case report and review of treatment options.
T hromboembolic disease is an important cause of morbidity and mortality during pregnancy. Berg and colleagues found that 11% of maternal deaths during pregnancy were related to pulmonary embolism (PE). Another study revealed that up to 40% of pregnant women with asymptomatic deep vein thrombosis (DVT) may also have concurrent PE. Women are at increased risk for DVT and PE during pregnancy for ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Turkish Journal of Hematology
سال: 2013
ISSN: 1300-7777
DOI: 10.4274/tjh.07641